•
Mar 31, 2024

Inhibrx Biosciences Inc Q1 2024 Earnings Report

EPS
-$1.44
Previous year: -$1.12
+28.6%
Gross Profit
-$360K
Cash and Equivalents
$252M
Free Cash Flow
-$64.2M
Previous year: -$40M
+60.6%
Total Assets
$289M

Inhibrx Biosciences Inc

Inhibrx Biosciences Inc